PHRRF
PharmaTher Holdings Ltd.
Set alert
0.04 USD 0.00 -5.00%
0.0397 Day range 0.0399
0.032 52-week range 0.121
- YTD
- -45.71%
- 1 year
- -53.66%
- Open
- 0.0397
- Prev close
- 0.04
- Mkt cap
- 3.46M
- Vol
- 3.50K
- Avg vol
- 116.69K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.0397
- High
- 0.0399
News
- PharmaTher Builds Portfolio of Personalized, 3D-Printed Peptide Products for New U.S. Peptide Pathway, Led by Colon-Targeted KPV and BPC-157
- PharmaTher Submits Orphan Drug and Rare Pediatric Disease Designation Applications to FDA for 3D-Printed Creatine Monohydrate in GAMT Deficiency
- PharmaTher Outlines Corporate Strategy and Upcoming Milestones; Launches New Corporate Website and Rebrands PERSONALIZ3D as M3DICINES
- PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform
- PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Shares Shorted: Short Interest Up 98.5% in September
- PharmaTher Establishes PERSONALIZ3D(TM) to Commercialize a Personalized Medicine Platform Combining Telehealth and Pharmaceutical 3D Printing
- PharmaTher Collaborates with Craft Health to Evaluate CraftMake(TM) GMP-Ready Pharmaceutical 3D Printing Platform for Personalized Peptides
- PharmaTher Launches Personaliz3D Peptides(TM) to Advance Personalized Peptide Care Following Positive FDA Advisory Committee Recommendations
- PharmaTher Enters into Collaboration Agreement for KetaMist(R) to Advance Needle-Free Ketamine Treatment Toward FDA Approval
- PharmaTher Updates Strategy on Personalized Medicines for Peptides and Psychedelics
Your note
Sign in to keep a note on PHRRF — it syncs with the Stock Master app.